Krüppel-like Factor 5 Shows Proliferation-specific Roles in Vascular Remodeling, Direct Stimulation of Cell Growth, and Inhibition of Apoptosis*

Krüppel-like factor 5 (KLF5), originally isolated as a regulator of phenotypic modulation of vascular smooth muscle cells, induces pathological cell growth and is expressed in the neointima. Although induction of KLF5 up-regulates growth factors like platelet-derived growth factor-A chain, how KLF5 actually contributes to vascular remodeling, notably its direct effects on cell proliferation, had been poorly clarified. To investigate the effects of KLF5 on neointimal formation, we at first performed adenoviral overexpression of KLF5 to rats subjected to carotid balloon injury. Neointimal formation and proliferating cell nuclear antigen-positive rate were significantly increased at 14 days after injury in the KLF5-treated animals. At the cellular level, overexpression of KLF5 also resulted in markedly increased cell proliferation and cell cycle progression. As a molecular mechanism, we showed that KLF5 directly bound to the promoter and up-regulated gene expression of cyclin D1, as well as showing specific transactivation of cyclins and cyclin-dependent kinase inhibitors in cardiovascular cells. Conversely, knockdown of KLF5 by RNA interference specifically down-regulated cyclin D1 and impaired vascular smooth muscle cell proliferation. Furthermore, KLF5 attenuated cleavage of caspase-3 under conditions of apoptotic stimulation. Moreover, KLF5-administered animals exhibited a significant decrease in terminal deoxynucleotidyltransferase-mediated dUTP nick end-labeling-positive cells in the medial layer, suggesting inhibition of apoptosis in the early phase after denudation. These findings collectively suggest that KLF5 plays a central role in cardiovascular pathologies through direct and specific stimulation of cell growth as well as inhibition of apoptosis.

[1]  B. Zlokovic,et al.  Myocardin Is Sufficient for a Smooth Muscle–Like Contractile Phenotype , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[2]  M. Horikoshi,et al.  Promoter Region-Specific Histone Incorporation by the Novel Histone Chaperone ANP32B and DNA-Binding Factor KLF5 , 2007, Molecular and Cellular Biology.

[3]  Giulio Gabbiani,et al.  The myofibroblast: one function, multiple origins. , 2007, The American journal of pathology.

[4]  V. Yang,et al.  Lysophosphatidic Acid Facilitates Proliferation of Colon Cancer Cells via Induction of Krüppel-like Factor 5* , 2007, Journal of Biological Chemistry.

[5]  M. Horikoshi,et al.  Functional Interaction between the Transcription Factor Krüppel-like Factor 5 and Poly(ADP-ribose) Polymerase-1 in Cardiovascular Apoptosis* , 2007, Journal of Biological Chemistry.

[6]  D. Rhie,et al.  Upregulation of rat Ccnd1 gene by exendin-4 in pancreatic beta cell line INS-1: interaction of early growth response-1 with cis-regulatory element , 2006, Diabetologia.

[7]  J. Simons,et al.  KLF5 promotes cell proliferation and tumorigenesis through gene regulationin the TSU‐Pr1 human bladder cancer cell line , 2006, International journal of cancer.

[8]  K. Fujiu,et al.  Synthetic Retinoid Am80 Suppresses Smooth Muscle Phenotypic Modulation and In-Stent Neointima Formation by Inhibiting KLF5 , 2005, Circulation research.

[9]  V. Andrés Control of vascular cell proliferation and migration by cyclin-dependent kinase signalling: new perspectives and therapeutic potential. , 2004, Cardiovascular research.

[10]  S. Friedman,et al.  Cyclin-Dependent Kinase Inhibition by the KLF6 Tumor Suppressor Protein through Interaction with Cyclin D1 , 2004, Cancer Research.

[11]  V. Yang,et al.  Krüppel-like factor 5 mediates the transforming activity of oncogenic H-Ras , 2004, Oncogene.

[12]  D. Tan,et al.  Intestinal Tumor Progression Is Associated with Altered Function of KLF5* , 2004, Journal of Biological Chemistry.

[13]  Toru Suzuki,et al.  Regulation of Platelet-derived Growth Factor-A Chain by Krüppel-like Factor 5* , 2004, Journal of Biological Chemistry.

[14]  A. Kimura,et al.  Positive and Negative Regulation of the Cardiovascular Transcription Factor KLF5 by p300 and the Oncogenic Regulator SET through Interaction and Acetylation on the DNA-Binding Domain , 2003, Molecular and Cellular Biology.

[15]  M. Kurabayashi,et al.  Smooth Muscle Cell Outgrowth from Coronary Atherectomy Specimens in vitro Is Associated with Less Time to Restenosis and Expression of a Key Transcription Factor KLF5/BTEB2 , 2003, Cardiology.

[16]  R. Nagai,et al.  Absence of p53 Leads to Accelerated Neointimal Hyperplasia After Vascular Injury , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[17]  L. Khachigian,et al.  Sp1 Inhibits Proliferation and Induces Apoptosis in Vascular Smooth Muscle Cells by Repressing p21WAF1/Cip1 Transcription and Cyclin D1-Cdk4-p21WAF1/Cip1 Complex Formation* , 2003, Journal of Biological Chemistry.

[18]  R. Urrutia,et al.  Sp1- and Krüppel-like transcription factors , 2003, Genome Biology.

[19]  Ceshi Chen,et al.  A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer , 2002, Oncogene.

[20]  H. Nishimatsu,et al.  Krüppel-like zinc-finger transcription factor KLF5/BTEB2 is a target for angiotensin II signaling and an essential regulator of cardiovascular remodeling , 2002, Nature Medicine.

[21]  C. Sherr D1 in G2 , 2002 .

[22]  J. Bieker Krüppel-like Factors: Three Fingers in Many Pies* , 2001, The Journal of Biological Chemistry.

[23]  J. Black,et al.  Sp1 and krüppel‐like factor family of transcription factors in cell growth regulation and cancer , 2001, Journal of cellular physiology.

[24]  Qingbo Xu,et al.  Smooth muscle cell apoptosis in arteriosclerosis , 2001, Experimental Gerontology.

[25]  Vincent W. Yang,et al.  Intestinal-enriched Krüppel-like Factor (Krüppel-like Factor 5) Is a Positive Regulator of Cellular Proliferation* , 2001, The Journal of Biological Chemistry.

[26]  H. Nishimatsu,et al.  Transcriptional Activation of the cyclin D1 Gene Is Mediated by Multiple Cis-Elements, Including SP1 Sites and a cAMP-responsive Element in Vascular Endothelial Cells* , 2001, The Journal of Biological Chemistry.

[27]  R. Nagai,et al.  INDUCIBLE EXPRESSION OF BASIC TRANSCRIPTION FACTOR-BINDING PROTEIN 2 (BTEB2), A MEMBER OF ZINC FINGER FAMILY OF TRANSCRIPTION FACTORS, IN CARDIAC ALLOGRAFT VASCULAR DISEASE1 , 2000, Transplantation.

[28]  J. Turkson,et al.  Induction of p21WAF1/CIP1 and cyclin D1 expression by the Src oncoprotein in mouse fibroblasts: role of activated STAT3 signaling , 2000, Oncogene.

[29]  Toru Suzuki,et al.  Regulated Expression of the BTEB2 Transcription Factor in Vascular Smooth Muscle Cells: Analysis of Developmental and Pathological Expression Profiles Shows Implications as a Predictive Factor for Restenosis , 2000, Circulation.

[30]  R. Weiss,et al.  p21Waf1/Cip1 Is an Assembly Factor Required for Platelet-derived Growth Factor-induced Vascular Smooth Muscle Cell Proliferation* , 2000, The Journal of Biological Chemistry.

[31]  P. Libby Changing concepts of atherogenesis , 2000, Journal of internal medicine.

[32]  S. Meloche,et al.  Differential regulation of p27(Kip1) expression by mitogenic and hypertrophic factors: Involvement of transcriptional and posttranscriptional mechanisms. , 2000, The Journal of cell biology.

[33]  G. Suske The Sp-family of transcription factors. , 1999, Gene.

[34]  Y. Yazaki,et al.  BTEB2, a Krüppel-like transcription factor, regulates expression of the SMemb/Nonmuscle myosin heavy chain B (SMemb/NMHC-B) gene. , 1999, Circulation research.

[35]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[36]  J. Gunn,et al.  Apoptosis and cell proliferation after porcine coronary angioplasty. , 1998, Circulation.

[37]  K Walsh,et al.  Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. , 1997, Circulation.

[38]  Charles J. Sherr,et al.  Mammalian G1 cyclins , 1993, Cell.

[39]  M. Peach,et al.  Angiotensin II Induces Hypertrophy, not Hyperplasia, of Cultured Rat Aortic Smooth Muscle Cells , 1988, Circulation research.